healthy, young, male subjects show a high degree of consistency both between subjects (Kd = 2.81 ± 0.27 nM; B,, = 63 ± 3 fmol/108 platelet: mean ± s.e.mean, n = 10) and between sampling occasions in a single subject (KSd= 3.28 nM± 13%; Bmax = 70 fmol/108 platelet ± 16%: mean ± coefficient of variation, n = 5). 6 There is no significant difference in the binding capacity of platelets from a group of elderly male subjects (mean age 73) compared to those from young males (mean age 27) or elderly females (mean age 77). The affinity of binding is slightly but significantly (P < 0.05) higher in the elderly male group compared to the two other groups.7 We conclude that [3H]-dihydroergocryptine binds to the a2-adrenoceptor of intact human platelets which is responsible for noradrenaline-induced platelet aggregation. The high consistency of the binding characteristics of [3H]-dihydroergocryptine indicate that this assay may be useful as a monitor of platelet o-adrenoceptor sensitivity in clinical investigation.